Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man
- PMID: 22975571
- DOI: 10.2169/internalmedicine.51.7596
Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man
Abstract
This report presents a case of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man, including an analysis of the virulence of the P.aeruginosa isolated from the patient. The patient was successfully treated with intensive care and antibiotic treatment. This study analyzed the pathogenicity of the isolated strain both in vivo (using a mouse pneumonia model) and in vitro (using biofilm production), but could not explain how an otherwise healthy young man developed such severe community-acquired P.aeruginosa pneumonia. Although rare in community-acquired pneumonia, P.aeruginosa infection should be considered in patients with severe rapidly progressive pneumonia.
Similar articles
-
Pseudomonas aeruginosa community-acquired pneumonia following soil ingestion: A case report.Int J Infect Dis. 2025 Jun;155:107894. doi: 10.1016/j.ijid.2025.107894. Epub 2025 Mar 21. Int J Infect Dis. 2025. PMID: 40122514
-
Community acquired Pseudomonas pneumonia in an immune competent host.BMJ Case Rep. 2012 May 26;2012:bcr0120125673. doi: 10.1136/bcr.01.2012.5673. BMJ Case Rep. 2012. PMID: 22669213 Free PMC article.
-
Successful treatment of a previously healthy woman with Pseudomonas aeruginosa community-acquired pneumonia with plasmapheresis.Intern Med. 2012;51(19):2809-12. doi: 10.2169/internalmedicine.51.7921. Epub 2012 Oct 1. Intern Med. 2012. PMID: 23037481
-
Community Acquired Pseudomonas Aeruginosa Pneumonia in a Young Athlete Man: A Case Report and Literature Review.Infect Disord Drug Targets. 2018;18(3):249-254. doi: 10.2174/1871526518666180410122531. Infect Disord Drug Targets. 2018. PMID: 29637871 Review.
-
Guidelines for community-acquired pneumonia in the ICU.Curr Opin Crit Care. 2004 Feb;10(1):59-64. doi: 10.1097/00075198-200402000-00010. Curr Opin Crit Care. 2004. PMID: 15166851 Review.
Cited by
-
Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa.Respir Med Case Rep. 2014 Mar 26;12:30-3. doi: 10.1016/j.rmcr.2014.03.002. eCollection 2014. Respir Med Case Rep. 2014. PMID: 26029534 Free PMC article.
-
Virulence Attributes and Host Response Assays for Determining Pathogenic Potential of Pseudomonas Strains Used in Biotechnology.PLoS One. 2015 Nov 30;10(11):e0143604. doi: 10.1371/journal.pone.0143604. eCollection 2015. PLoS One. 2015. PMID: 26619347 Free PMC article.
-
30-day mortality in UK patients with bacteraemic community-acquired pneumonia.Infection. 2013 Oct;41(5):1005-11. doi: 10.1007/s15010-013-0462-7. Epub 2013 May 24. Infection. 2013. PMID: 23703286
-
[Multidisciplinary approach of ventilated necrotizing pneumonia].Reanimation. 2013;22(1):34-44. doi: 10.1007/s13546-012-0646-7. Epub 2013 Mar 13. Reanimation. 2013. PMID: 32288731 Free PMC article. French.
-
Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa.IDCases. 2019 May 16;17:e00563. doi: 10.1016/j.idcr.2019.e00563. eCollection 2019. IDCases. 2019. PMID: 31193456 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources